Kolinsky Wealth Management LLC Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Kolinsky Wealth Management LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,114 shares of the healthcare conglomerate’s stock after selling 77 shares during the period. UnitedHealth Group makes up approximately 0.8% of Kolinsky Wealth Management LLC’s investment portfolio, making the stock its 17th largest holding. Kolinsky Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,236,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Park Place Capital Corp boosted its position in UnitedHealth Group by 1.8% in the 2nd quarter. Park Place Capital Corp now owns 4,251 shares of the healthcare conglomerate’s stock worth $2,165,000 after purchasing an additional 74 shares in the last quarter. Davis Capital Management increased its holdings in UnitedHealth Group by 29.1% in the second quarter. Davis Capital Management now owns 989 shares of the healthcare conglomerate’s stock valued at $489,000 after buying an additional 223 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of UnitedHealth Group by 92.2% during the 2nd quarter. GAMMA Investing LLC now owns 10,206 shares of the healthcare conglomerate’s stock worth $5,198,000 after acquiring an additional 4,897 shares in the last quarter. Massmutual Trust Co. FSB ADV increased its stake in shares of UnitedHealth Group by 0.6% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 48,531 shares of the healthcare conglomerate’s stock valued at $24,715,000 after purchasing an additional 282 shares in the last quarter. Finally, M&R Capital Management Inc. boosted its position in UnitedHealth Group by 3.7% during the second quarter. M&R Capital Management Inc. now owns 6,368 shares of the healthcare conglomerate’s stock worth $3,243,000 after purchasing an additional 228 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently issued reports on UNH shares. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. TD Cowen boosted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Stephens decreased their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Finally, Barclays raised their price target on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research note on Wednesday. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $618.26.

UnitedHealth Group Stock Performance

Shares of UNH opened at $610.53 on Friday. The stock has a 50-day simple moving average of $585.43 and a 200-day simple moving average of $556.08. The stock has a market capitalization of $561.86 billion, a PE ratio of 39.77, a PEG ratio of 1.79 and a beta of 0.58. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.56 earnings per share. On average, analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.